Search
The Newsletter
The Principals
Reports
Conferences
Physician Surveys
Consulting
Contact Us
 
Home
 


“Investment In Innovation (In3):  
A Preview of Early-Stage Medical Technology Companies”

Palace Hotel, San Francisco, California

Program Agenda 

Wednesday, June 11, 2003

6:00 pm – 8:00 pm

Early Registration

6:00 pm – 8:00 pm

Pre-Conference Reception

Thursday, June 12, 2003

7:00 am

Registration and Continental Breakfast

8:00 am

Welcome/Opening – Sharon O’Reilly 
President and CEO
Medtech Insight, LLC

8:15 am

Keynote Speaker
The Current Environment for Medical Device Technology
Thomas Fogarty, M.D., Clinical Professor of Surgery, Stanford; President, Fogarty Research; General Partner, Three Arch Partners

9:15 am – 11:40 am

Company Presentations

9:15 am

Moderators – Nicole Lammers
Account Manager
Battelle Healthcare Products
and Adam L. Smith
Director of Sales
Zevex International, Inc.

9:20

Pathway Medical Technologies, Inc.

9:30

Cyberkinetics, Inc.

9:40

Impres Medical, Inc.

9:50

Biosensor Systems Design, Inc.

10:00

Zylon Corporation

10:10 am

Moderator – Carolyn R. Moora
President
Reimbursement Principles, Inc.

10:15

Light Sciences Corporation

10:25

PrISMedical Corporation

10:35

Sontra Medical Corporation

10:45

Z-KAT, Inc.

10:55

Power Medical Interventions, Inc.

11:05 am

Moderator – George Blank
President
The MedTech Group, Inc.

11:10

Pelikan Technologies, Inc.

11:20

NeoMed Technologies, Inc.

11:30

Transvivo, Inc.

11:40 am

Welcome/Introduction – Scott Pantel 
Vice President, Sales & Marketing
Medtech Insight, LLC

11:45 am - 12:00 pm

Featured Speaker
"Cost Effective Patent Protection"
Robert D. Fish, Partner

Rutan & Tucker, LLP

12:00 pm – 1:00 pm

Networking Buffet Lunch

1:00 pm

Introduction – Scott Pantel 
Vice President, Sales & Marketing
Medtech Insight, LLC

1:05 pm – 1:35 pm

Featured Speaker
Securing Global Product Acceptance:  Principles & Practices in International Regulatory Affairs
Harvey Rudolph, Ph.D.
Global Program Manager, Medical Devices
Underwriters Laboratories, Inc.

1:35 pm – 5:15 pm

Company Presentations

1:35 pm

Moderator – Catherine Barale
General Manager, High Tech Strategic
Business Units

Underwriters Laboratories, Inc.

1:40

Innovative Spinal Technologies, Inc.

1:50

Advanced BioSensors, Inc.

2:00

Xillix Technologies Corporation

2:10

Nervonix, Inc.

2:20

Doctors Research Group, Inc.

2:30

Sleep Solutions, Inc.

2:40 pm

Moderator – Stephen Levin
COO/General Counsel & Senior Staff Writer
Windhover Information, Inc.

2:45

TransVascular, Inc.

2:55

Accuray, Inc.

3:05

Vascular BioSciences, Inc.

3:15

Vitalog, Inc.

3:25

BioPlastiQ, Inc.

3:35 pm

Moderator – Vicki Dallas
Partner
Rutan & Tucker, LLP

3:40

PhysioAdvantage, LLC

3:50

Starion Instruments Corporation

4:00

Intelligent Clothing, Ltd.

4:10

WaveScan, Inc.

4:20 pm

Moderator – David Palmer
Vice President, Business Development
Pittsburgh Life Sciences Greenhouse

4:25

Bonecraft, Inc.

4:35

Agentase, LLC

4:45

Acoustic MedSystems, Inc.

4:55

Hemonix, Inc.

5:05

IDev Technologies, Inc.

5:30 pm – 6:30 pm

Sponsor-Supported Networking Session

6:30 pm – 8:30 pm

Tabletop Exhibits Open
Buffet Dinner in Exhibit Area

Friday, June 13, 2003

7:00 am

Continental Breakfast

8:00 am

Welcome/Opening – Sharon O’Reilly 
President and CEO
Medtech Insight, LLC

8:10 am

Featured Speaker
"Medical Devices:  A Hedging Strategy for Venture Capital?"
Ellen Koskinas, Principal
InterWest Partners

8:45 am – 12:55 pm

Company Presentations

8:45 am

Moderator – Cynthia Melocik
National Business Development Specialist
Medmarc and The Hartford

8:50

Vector II, Inc.

9:00

CardioEnergetics, Inc.

9:10

Duke Empirical, Inc.

9:20

MedOptix, Inc.

9:30

BioLuminate, Inc.

9:40 am

Moderator – Andrew Calhoun
Director of Memberships
AdvaMed, Advanced Medical Technology Association

9:45

CardioFocus, Inc.

9:55

Cannuflow, Inc.

10:05

EndoBionics, Inc.

10:15

CathEffects, LLC

10:25

InMedica Development Corporation

10:35 am

Moderators – Denise Forkey, MSBME, Director of Operations and Regulatory Compliance
and Thom Wehman, Ph.D., Director of
Corporate Development
LyChron, LLC

10:40

TheraJect, Inc.

10:50

IntraLuminal Therapeutics, Inc.

11:00

BioMedix, Inc.

11:10

MDG Medical, Inc.

11:20

Imalux Corporation

11:30 am

Moderator – France Helfer
Vice President, Business Development
Clinsights, Inc.

11:35

VascuSense, Inc.

11:45

LifeWave, Inc.

11:55

Polymerix Corporation

12:05

Tosk, Inc.

12:15

Mazor Surgical Technologies, Ltd.

12:25

The Medipattern Corporation

12:35

Harbinger Medical, Inc.

12:45

DermaHealth Systems Corporation

1:00 pm – 3:00 pm

Luncheon and Industry Panel Discussion

1:30 pm – 3:00 pm

"Corporate Equity Investing"

Moderator

Dan Sullivan, Key Executive, Scimed Life Systems; Co-Founder, Vascular Science, Atritech, and SRTI

Panelists:  
*Dr. Michael Chobotov, President & CEO, TriVascular, Inc.
*Mark J. Foley, President & CEO, Ventrica, Inc.
*Sami Hamade, Vice President, Business Development,
   Guidant Corporation

3:00 pm

Adjournment

Co-sponsored by:


     

 

 

 

 

   

 

   

   

 

 

 

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

   

 

 

 

 

 

   

 

 

 

 

 

 

 

 

 

 

Return to In3 San Francisco conference page.

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home